In addition, Metformin was reported to influence immune cell infiltration, with an increased presence of CD8+ effector T cells and FoxP3+ regulatory T cells at the invasive tumor margin of lymph nodes with extracapsular extension [45], suggesting potential immune modulation, although the functional consequences of this altered immune profile remain to be fully elucidated. Here, CD8A is linked to neoplasm.